| Literature DB >> 26618047 |
Gargi Chatterjee1, Debashree Roy1, Vineet Kumar Khemka1, Mrittika Chattopadhyay1, Sasanka Chakrabarti1.
Abstract
The isoflavone, genistein, present in soybean is being actively investigated for its potential beneficial effect against Alzheimer's disease. Our data, however, show that in SHSY5Y cells genistein causes increased expression (mRNA and protein) of amyloid precursor protein (APP), increased mRNA expression and activity of β-secretase and diminished level of insulin degrading enzyme (IDE) which also degrades amyloid beta peptide. These effects of genistein lead to enhanced accumulation of amyloid beta peptide (Aβ42) in SHSY5Y cells. The results do not support the view that genistein could be a putative drug against AD and instead strengthen the epidemiological study which implies that genistein content of soybean food product (Tofu) leads to cognitive impairment.Entities:
Keywords: Alzheimer’s disease; amyloid precursor protein; amyloid β42.; genistein; insulin degrading enzyme; β-secretase
Year: 2015 PMID: 26618047 PMCID: PMC4657817 DOI: 10.14336/AD.2015.0327
Source DB: PubMed Journal: Aging Dis ISSN: 2152-5250 Impact factor: 6.745